Researchers analyze incidence of COVID-19-associated pulmonary aspergillosis in Japan

As society learns to live with COVID-19, research on the disease and its complications remains important.

AI in drug discovery is ‘nonsense,’ but call Schrödinger ‘AI’ if you want, says CEO

Schrödinger CEO Ramy Farid wants you to know that his company isn’t an AI company…but he’ll call it that if you want to. The company,

November 20, 2024

Aceragen to pull out of Nasdaq and liquidate assets, ending tumultuous journey for Idera Pharma

Aceragen is set to cease its Nasdaq listing, the next step for the beleaguered company whose assets are slated to be liquidated. The company has

August 8, 2023

Cracking the code: recent discoveries transform our understanding of cancer-immunity cycle

In a recent review published in Immunity, researchers reviewed tumor-immunity cycle data.

October 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.